depression ketamine - Search News

US FDA approves new nasal spray for depression treatment

Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.

Fox Business · 1d

J&J's ketamine-derived nasal spray approved by FDA to treat depression

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.

Popular Science · 8h

FDA approves first-of-its-kind nasal spray for severe depression

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and similar psychiatric conditions.

3don MSN

Research indicates recreational ketamine use is on the rise

Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...

Ketamine-Induced Uropathy: What Urologists Need to Know

A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...

Inquirer on MSN2d

Controlled drug Ketamine a lifeline for patients with severe depression in S’pore

Ketamine therapy is now a mainstream prescription for treatment-resistant depression. Read more at straitstimes.com.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results